MTS Health Investors Purchases DNA Diagnostics Center

MTS Health Investors, LLC (MTS; New York, NY, USA) has purchased DNA Diagnostics Center, Inc. (DDC; Fairfield, OH, USA) and related entities. Terms of the transaction were not disclosed.

MTS Health Investors is a healthcare private equity firm that focuses on areas such as managed care/health insurance, providers of healthcare services, distributors of medical products, and providers of outsourced services to the healthcare industry. The firm also invests in manufacturers of low-technology medical products.

DDC is one of the largest and most reputable DNA testing laboratories worldwide and a leader in human DNA identification testing for the private sector. The Company has provided DNA testing for numerous high-profile legal disputes. DDC provides a wide array of DNA testing services in the fields of biological family relationships, forensics, and veterinary genetics.

Dr. Ellen Moscovitz, who has over 20 years of experience in the DNA testing industry, is joining DDC as CEO. "I am excited to join DDC and partner with MTS," said Dr. Moscovitz. "I look forward to building on the company's leadership position and stellar reputation within the DNA testing services industry."

Dr. Michael Baird, a pioneer and one of the foremost authorities in the DNA testing industry, will continue in his current capacity as laboratory director. Dr. Baird said, "We are pleased to partner with MTS and Dr. Moscovitz to further the success of the Company and pursue additional opportunities within the DNA testing arena."

Related Links:
MTS Health Investors
DNA Diagnostics Center, Inc.